Trials / Completed
CompletedNCT01776697
Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects
A Randomized, Open-labeled, Comparative 3-way Crossover Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-labeled, comparative 3-way crossover study to compare the pharmacokinetic characteristics and food effect of pelubiprofen (30mg) tablet IR TID and pelubiprofen SR (as a pelubiprofen 90 mg) tablet QD in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pelubiprofen (30mg) tablet IR | |
| DRUG | pelubiprofen SR (as a pelubiprofen 90 mg) tablet |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2013-01-28
- Last updated
- 2013-01-28
Source: ClinicalTrials.gov record NCT01776697. Inclusion in this directory is not an endorsement.